BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22490371)

  • 1. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
    Davis RC; Hobbs FD; Kenkre JE; Roalfe AK; Iles R; Lip GY; Davies MK
    Europace; 2012 Nov; 14(11):1553-9. PubMed ID: 22490371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
    Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation.
    Proietti M; Marra AM; Tassone EJ; De Vuono S; Corrao S; Gobbi P; Perticone F; Corazza GR; Basili S; Lip GY; Violi F; Raparelli V; ;
    Am J Cardiol; 2015 Sep; 116(6):877-82. PubMed ID: 26183791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.
    Lip GY; Golding DJ; Nazir M; Beevers DG; Child DL; Fletcher RI
    Br J Gen Pract; 1997 May; 47(418):285-9. PubMed ID: 9219403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Atrial Fibrillation in Lower Limb Amputee Patients.
    Ralevic S; Perunicic J; Lasica R; Marinkovic J; Blagojevic T; Simanic I; Asanin M; Stankovic G
    Eur J Vasc Endovasc Surg; 2016 Dec; 52(6):823-829. PubMed ID: 27789143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
    Hess PL; Greiner MA; Fonarow GC; Klaskala W; Mills RM; Setoguchi S; Al-Khatib SM; Hernandez AF; Curtis LH
    Clin Cardiol; 2012 Nov; 35(11):649-57. PubMed ID: 23070696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: prevalence in a large database of primary care patients in Brazil.
    Marcolino MS; Palhares DM; Benjamin EJ; Ribeiro AL
    Europace; 2015 Dec; 17(12):1787-90. PubMed ID: 26056188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Functional Status to Risk of Development of Atrial Fibrillation.
    Ramkumar S; Yang H; Wang Y; Nolan M; Negishi K; Sanders P; Marwick TH
    Am J Cardiol; 2017 Feb; 119(4):572-578. PubMed ID: 27956001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.
    Krittayaphong R; Rangsin R; Thinkhamrop B; Hurst C; Rattanamongkolgul S; Sripaiboonkij N; Yindeengam A
    BMC Cardiovasc Disord; 2016 Mar; 16():57. PubMed ID: 27004563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment for incident heart failure in individuals with atrial fibrillation.
    Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
    Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study.
    Bardai A; Blom MT; van Hoeijen DA; van Deutekom HW; Brouwer HJ; Tan HL
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1033-9. PubMed ID: 25236735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.